News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,230 Results
Type
Article (86991)
Company Profile (704)
Press Release (766533)
Multimedia
Podcasts (152)
Webinars (20)
Section
Business (232874)
Career Advice (4133)
Deals (39768)
Drug Delivery (130)
Drug Development (91135)
Employer Resources (199)
FDA (18209)
Job Trends (17372)
News (396959)
Policy (39841)
Tag
Academia (3002)
Academic (2)
Accelerated approval (14)
Adcomms (33)
Allergies (109)
Alliances (56977)
ALS (123)
Alzheimer's disease (1614)
Antibody-drug conjugate (ADC) (192)
Approvals (18163)
Artificial intelligence (409)
Autoimmune disease (39)
Automation (21)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (103)
Brain cancer (42)
Breast cancer (408)
Cancer (3208)
Cardiovascular disease (258)
Career advice (3542)
Career pathing (34)
CAR-T (214)
CDC (43)
Cell therapy (591)
Cervical cancer (25)
Clinical research (74493)
Collaboration (1155)
Company closure (3)
Compensation (744)
Complete response letters (39)
COVID-19 (2915)
CRISPR (70)
C-suite (391)
Cystic fibrosis (125)
Data (3264)
Decentralized trials (2)
Denatured (54)
Depression (83)
Diabetes (384)
Diagnostics (6995)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (193)
Drug pricing (156)
Drug shortages (36)
Duchenne muscular dystrophy (161)
Earnings (97839)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131634)
Executive appointments (927)
FDA (20088)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1039)
Gene editing (152)
Generative AI (42)
Gene therapy (463)
GLP-1 (946)
Government (5287)
Grass and pollen (7)
Guidances (222)
Healthcare (20921)
HIV (46)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (194)
Immuno-oncology (13)
Indications (42)
Infectious disease (3120)
Inflammatory bowel disease (167)
Inflation Reduction Act (13)
Influenza (78)
Intellectual property (130)
Interviews (813)
IPO (17907)
IRA (57)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (60)
Layoffs (602)
Leadership (27)
Legal (10139)
Liver cancer (85)
Longevity (12)
Lung cancer (449)
Lymphoma (225)
Machine learning (13)
Management (65)
Manufacturing (479)
MASH (104)
Medical device (14751)
Medtech (14758)
Mergers & acquisitions (22615)
Metabolic disorders (978)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (165)
Neuropsychiatric disorders (47)
Neuroscience (2410)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (497)
Opinion (293)
Ovarian cancer (108)
Pain (128)
Pancreatic cancer (133)
Parkinson's disease (204)
Partnered (25)
Patents (340)
Patient recruitment (188)
Peanut (55)
People (65800)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22977)
Phase II (32344)
Phase III (24365)
Pipeline (1791)
Policy (253)
Postmarket research (3554)
Preclinical (10380)
Press Release (72)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (545)
Real estate (7402)
Recruiting (76)
Regulatory (27325)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (105)
Series A (174)
Series B (120)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4307)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (71)
The Weekly (96)
Vaccines (940)
Venture capital (60)
Weight loss (334)
Women's health (52)
Worklife (20)
Date
Today (48)
Last 7 days (567)
Last 30 days (1931)
Last 365 days (33716)
2025 (19769)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1277)
Alabama (72)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50603)
Australia (8892)
California (8036)
Canada (2489)
China (745)
Colorado (342)
Connecticut (358)
Delaware (215)
Europe (116138)
Florida (1199)
Georgia (274)
Hawaii (3)
Idaho (67)
Illinois (759)
India (34)
Indiana (396)
Iowa (19)
Japan (248)
Kansas (117)
Kentucky (34)
Louisiana (19)
Maine (73)
Maryland (1135)
Massachusetts (6150)
Michigan (280)
Minnesota (501)
Mississippi (4)
Missouri (107)
Montana (32)
Nebraska (26)
Nevada (87)
New Hampshire (74)
New Jersey (2253)
New Mexico (31)
New York (2238)
North Carolina (1267)
North Dakota (10)
Northern California (3492)
Ohio (260)
Oklahoma (17)
Oregon (48)
Pennsylvania (1721)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2991)
Tennessee (132)
Texas (1245)
United States (30299)
Utah (234)
Virginia (221)
Washington D.C. (80)
Washington State (706)
West Virginia (4)
Wisconsin (87)
There are 854,230 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results
August 4, 2025
·
25 min read
Press Releases
BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter
August 4, 2025
·
6 min read
Press Releases
AB Science announces the successful completion of a 2.55 million euros private placement
August 4, 2025
·
11 min read
Press Releases
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
August 4, 2025
·
2 min read
Press Releases
Pharming Group to participate in August 2025 investor conference
August 4, 2025
·
1 min read
Press Releases
EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing
August 4, 2025
·
1 min read
Press Releases
Akeso Announces Approval to Initiate Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma
August 4, 2025
·
7 min read
Press Releases
Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease
August 4, 2025
·
4 min read
Press Releases
BioXcel Therapeutics Announces Last Patient Last Visit in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
August 4, 2025
·
9 min read
Press Releases
Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader
August 4, 2025
·
14 min read
1 of 85,423
Next
